Belite Bio, Inc (ADR)
General ticker "BLTE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.4B (TTM average)
Belite Bio, Inc (ADR) follows the US Stock Market performance with the rate: 39.3%.
Estimated limits based on current volatility of 2.0%: low 145.80$, high 151.61$
Factors to consider:
- Total employees count: 16 as of 2022
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [77.74$, 165.90$]
- 2026-12-31 to 2027-12-31 estimated range: [51.15$, 117.21$]
Financial Metrics affecting the BLTE estimates:
- Negative: with PPE of -79.3 at the end of fiscal year the price was very high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Investing cash flow per share per price, % of -5.79 <= -4.39
- Positive: Shareholder equity ratio, % of 98.71 > 64.23
Short-term BLTE quotes
Long-term BLTE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $31.67MM | $40.00MM | $84.21MM |
| Operating Income | $-31.67MM | $-40.00MM | $-84.21MM |
| Non-Operating Income | $0.04MM | $3.86MM | $6.60MM |
| Interest Expense | $0.03MM | $0.02MM | $0.00MM |
| R&D Expense | $24.84MM | $29.94MM | $45.38MM |
| Income(Loss) | $-31.62MM | $-36.14MM | $-77.61MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-31.63MM | $-36.14MM | $-77.61MM |
| Stockholders Equity | $90.43MM | $145.82MM | $770.49MM |
| Assets | $94.64MM | $152.13MM | $780.56MM |
| Operating Cash Flow | $-29.84MM | $-29.23MM | $-36.99MM |
| Capital expenditure | $0.06MM | $0.15MM | $0.18MM |
| Investing Cash Flow | $-0.06MM | $-110.57MM | $-305.11MM |
| Financing Cash Flow | $75.96MM | $83.59MM | $663.23MM |
| Earnings Per Share** | $-1.19 | $-1.18 | $-2.31 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.